Correction: Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy

Nature Communications 8: Article number: 14454 (2017); Published: 14 February 2017; Updated: 23 June 2017 This Article contains an error in Fig. 4, for which we apologize. In panel a, the image reporting dystrophin labelling following SaCas9Δ5253 treatment was inadvertently duplicated from the corre...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 8; no. 1; p. 1
Main Authors Bengtsson, Niclas E., Hall, John K., Odom, Guy L., Phelps, Michael P., Andrus, Colin R., Hawkins, R. David, Hauschka, Stephen D., Chamberlain, Joel R., Chamberlain, Jeffrey S.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 23.06.2017
Nature Portfolio
Subjects
631/208/4041/3196
692/699/375/374
corrigendum
Erratum
Humanities and Social Sciences
multidisciplinary
Science
Science (multidisciplinary)
Online AccessGet full text

Cover

More Information
Summary:Nature Communications 8: Article number: 14454 (2017); Published: 14 February 2017; Updated: 23 June 2017 This Article contains an error in Fig. 4, for which we apologize. In panel a, the image reporting dystrophin labelling following SaCas9Δ5253 treatment was inadvertently duplicated from the corresponding image following SpCas9/Δ5253 treatment.
Bibliography:correction
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms16007